HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
STOP PRESS: Novartis in "white knight" talks with Aventis.(Aventis Pharma Deutschland GmbH)(Brief Article)
-
Pharma Marketletter; Mar 1, 2004; 517 Words
STOP PRESS: Swiss drug major Novartis is in preliminary talks with Franco-German Aventis to act as a "white knight" in the latter's bid to fend off the hostile...
-
-
Roche Consumer Health Deutschland GmbH among others are examined in the Medicated Skincare in Germany Report.
-
M2 Presswire; Mar 3, 2006; 700+ Words
...Markets: Roche Consumer Health Deutschland GmbH among others are examined...Mentioned Include: - Bayer Vital GmbH- Novartis Consumer Health GmbH- Boehringer Ingelheim Pharma...AG- Roche Consumer Health Deutschland GmbH- Whitehall Much GmbH...
-
-
Research and Markets: Roche Consumer Health Deutschland GmbH Among Others Are Examined in the Medicated Skincare in Germany Report.
-
Business Wire; Mar 6, 2006; 700+ Words
...Companies Mentioned Include: - Bayer Vital GmbH - Novartis Consumer Health GmbH - Boehringer Ingelheim Pharma GmbH & Co...Stada Arzneimittel AG - Roche Consumer Health Deutschland GmbH - Whitehall Much GmbH - MCM Klosterfrau Vertriebgesellschaft...
-
-
Anti-Alzheimers Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinsons Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) are Classified inside 2006 Global Strategic Business Report.
-
M2 Presswire; Nov 24, 2006; 700+ Words
...Inc (USA)Newron Pharmaceuticals SpA (Italy)Novartis AG (Switzerland)Novartis Pharmaceuticals Corporation (USA)Novartis Deutschland GmbH (Germany)Novartis Pharma GmbH (Germany)NsGene A/S (Denmark)Nymox Pharmaceutical Corporation...
-
-
Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) are Classified inside 2006 Global Strategic Business Report.
-
Business Wire; Nov 27, 2006; 700+ Words
...Inc (USA) Newron Pharmaceuticals SpA (Italy) Novartis AG (Switzerland) Novartis Pharmaceuticals Corporation (USA) Novartis Deutschland GmbH (Germany) Novartis Pharma GmbH (Germany) NsGene A/S (Denmark) Nymox Pharmaceutical Corporation...
-
-
Asthma, Allergic Rhinitis and COPD (Chronic Obstructive Pulmonary Disease) are Some Segments Respiratory Drugs Address.
-
Business Wire; Aug 22, 2006; 700+ Words
...Biopharmaceuticals (USA) Activaero GmbH (Germany) Actavis (Iceland...UK) Boehringer Ingelheim GmbH (Germany) Boehringer Ingelheim...Nigaard Pharma AS (Norway) Novartis AG (Switzerland) Sandoz Deutschland GmbH (Germany) OM Pharma (Switzerland...
-
-
Use Five-year Forecasts to Assess How the German Eye Care Market is Expected to Develop.
-
Business Wire; Aug 24, 2006; 700+ Words
...Companies Mentioned Include: - McNeil GmbH & Co oHG - Pfizer Pharma GmbH - Novartis Consumer Health GmbH - Boots Healthcare Deutschland - Bayer Vital GmbH - Novartis Consumer Health GmbH - Boehringer Ingelheim Pharma GmbH & Co KG - Beiersdorf...
-
-
Eye Care in Germany - Forecasts to 2013.
-
M2 Presswire; Nov 20, 2009; 700+ Words
...Mentioned: Companies Mentioned Include: - McNeil GmbH & Co oHG - Pfizer Pharma GmbH - Novartis Consumer Health GmbH - Boots Healthcare Deutschland - Bayer Vital GmbH - Novartis Consumer Health GmbH - Boehringer Ingelheim Pharma GmbH & Co KG - Beiersdorf...
-
-
Intense Competition in the Global Antidepressants Marketplace.
-
Business Wire; Sep 1, 2006; 700+ Words
...Lundbeck A/S, Merck & Co., Novartis AG, Organon International, Inc...Neurosearch A/S (Denmark) - Novartis AG (Switzerland) - Sandoz, Inc (Austria) - Sandoz Deutschland GmbH (Germany) - Olympian Labs (USA...
-
-
Novartis AG to Acquire Eon Labs, Inc.; Eon Announces Preliminary Fourth Quarter 2004 Financial Results.
-
Business Wire; Feb 21, 2005; 700+ Words
...agreement pursuant to which Novartis will acquire Eon Labs...owned subsidiary of Novartis will commence a cash...held by Santo Holding (Deutschland) GmbH (Eon's controlling...per share in cash. Novartis also announced that...
-
-
Novartis to buy Hexal and Eon to create generics behemoth through Sandoz.
-
Pharma Marketletter; Feb 28, 2005; 700+ Words
...pharmaceutical company Novartis has announced plans...announced on February 21, Novartis says it has entered...owned by Santo Holding (Deutschland) GmbH (Eon's controlling...65 billion euros. Novartis will also purchase all...
-
-
FTC approves Novartis' $1.7 billion buy of Eon Labs
-
AP Worldstream; Jul 19, 2005; ; 346 Words
...closes, the FTC said. Novartis received clearance from...in May. On Tuesday, Novartis said it has now received...regulatory approvals. Novartis's $31 per share tender...owned by Santo Holding (Deutschland) GmbH shortly after the tender...
-
-
Identify the Factors Driving Change in the Cough, Cold & Allergy (Hay Fever) Remedies Market in Germany.
-
Business Wire; Aug 22, 2006; 700+ Words
...Aventis Pharma Deutschland GmbH (Nattermann &...Company Profile - Novartis Consumer Health GmbH...Include: - Bayer Vital GmbH - Novartis Consumer Health GmbH - Boehringer Ingelheim...Boots Healthcare Deutschland GmbH - Roche Consumer...
-
-
All Sectors Except Digestive Remedies Experienced Growth in the German OTC Market.
-
Business Wire; Aug 17, 2006; 700+ Words
...Aventis Pharma Deutschland GmbH (Nattermann &...Company Profile - Novartis Consumer Health GmbH...Include: - Bayer Vital GmbH - Novartis Consumer Health GmbH - Boehringer Ingelheim...Boots Healthcare Deutschland GmbH - Roche Consumer...
-
-
Identify the Key Factors Influencing the Vitamins and Dietary Supplements Market in Austria.
-
Business Wire; Mar 27, 2007; 700+ Words
...amp; Co KG - Wyeth-Lederle Pharma GmbH - Queisser Pharma GmbH & Co - Novartis Consumer - Health-Gebro GmbH - STADA Arzneimittel AG - Genericon...Sanochemia Pharmazeutika AG - Pharmacia Deutschland GmbH For more information visit http...
-
-
Biochemie and Antibioticos Share Cephalosporins Lead
-
Chemical Market Reporter; Aug 31, 1998; ; 700+ Words
...a key market. WITH THE ACQUISITION of Hoechst Marion Roussel Deutschland GmbH's Frankfurt, Germany site, Biochemie GmbH, the Austria-based antibiotics subsidiary of Novartis, gains equal leverage in the antibiotics market against former...
-
-
Biochemie and Antibioticos Share Cephalosporins Lead.
-
Chemical Market Reporter; Aug 31, 1998; ; 700+ Words
...a key market. WITH THE ACQUISITION of Hoechst Marion Roussel Deutschland GmbH's Frankfurt, Germany site, Biochemie GmbH, the Austria-based antibiotics subsidiary of Novartis, gains equal leverage in the antibiotics market against former...
-
-
Research and Markets: Key Insights into Russia's Pharmaceutical Market.
-
Business Wire; Jul 8, 2005; 700+ Words
...Union DHU-Arzneimittel GmbH&Co. KG --Dr...Egis --Esparma GmbH --Ferring Pharmaceuticals...Ferrosan --Fresenius Kabi Deutschland GmbH --G. Pohl-Boskamp...Mundipharma --Nestle --Novartis --Novo Nordisk...
-
-
Bioinvestors Converge in Munich for EC21; Meeting Presents Ideal Platform for Bioinvestment Insight.
-
PR Newswire; Mar 13, 2002; 700+ Words
...Sofinnova Partners, 3i Deutschland, Warburg Pincus and...AG, Fresenius Kabi Deutschland GmbH, GENFIT, Heidrick...N.U.S.T., Novartis Corporation, Omrix...GlycoSciences. Speakers: 3i Deutschland Ges. fur Industriebeteiligungen...
-
-
EC21 - Bioinvestment Showcase Increasing Industry Insight.
-
PR Newswire; Feb 27, 2002; 700+ Words
...Warburg Pincus, 3i Deutschland and Alice Ventures...AG, Fresenius Kabi Deutschland GmbH, GENFIT, Heidrick...N.U.S.T., Novartis Corporation, Omrix...GlycoSciences. Speakers: 3i Deutschland Ges. fur Industriebeteiligungen...
|
|